Questions and Answers on Informed Consent Elements, 21 CFR § 5025(c): Guidance for Sponsors, Investigators, and Institutional Review Boards
Detailed guidance document from FDA and regulatory agencies.
Document Details
Small Entity Compliance Guide
February 1, 2012
April 19, 2019
f08c5611-e030-4503-853b-be8ace821598
Related Documents
Evaluation of Sex Differences in Clinical Investigations: Guidance for Industry
Small Entity Compliance GuideJanuary 20, 2025Office of the Commissioner
Significant Risk and Nonsignificant Risk Medical Device Studies: Guidance For IRBs, Clinical Investigators, and Sponsors
Small Entity Compliance GuideJanuary 1, 2006Office of the Commissioner
Informed Consent: Guidance for IRBs, Clinical Investigators, and Sponsors
Small Entity Compliance GuideAugust 15, 2023Office of the Commissioner
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.